Ameliorative Effects of a Combination of Baicalin, Jasminoidin and Cholic Acid on Ibotenic Acid-Induced Dementia Model in Rats

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Zhang, Junying ^a,b   Li, Peng ^c   Wang, Yanping ^d   Liu, Jianxun ^c   Zhang, Zhanjun ^b   Cheng, Weidong ^a   Wang, Yongyan ^d  

^a LANZHOU UNIVERSITY   (China)

^b BEIJING NORMAL UNIVERSITY   (China)

^c XIYUAN HOSPITAL   (China)

^d INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BAICALIN PLUS CHOLIC ACID PLUS JASMINOIDIN; CHINESE DRUG; DNA; FLUORODEOXYGLUCOSE F 18; NEUROPROTECTIVE AGENT; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHOLESTEROL METABOLISM; COGNITIVE DEFECT; CONTROLLED STUDY; DNA MICROARRAY; DRUG STRUCTURE; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; MALE; MAZE TEST; NERVE CELL DIFFERENTIATION; NEUROIMAGING; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PROTEIN DEGRADATION; RAT; WESTERN BLOTTING;

ALZHEIMER DISEASE; ANIMALS; CHOLIC ACID; DEMENTIA; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; DRUGS, CHINESE HERBAL; FLAVONOIDS; HUMANS; IBOTENIC ACID; IRIDOIDS; MALE; NEUROPROTECTIVE AGENTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS;

EID: 84874260879     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056658     Document Type: Article

References (79)

1. Klafki HW, Staufenbiel M, Kornhuber J, Wiltfang J, (2006) Therapeutic approaches to Alzheimer's disease. Brain 129: 2840-2855.
2. Guo X, Lai S, (2000) Meta-analysis of Qingkailing Injection for Treating Acute Stroke. Guang Zhou Zhong Yi Yao Da Xue Xue Bao 17: 9-14.
3. Lee K, Wang H, Itokawa H, Morris-Natschke SL, (2000) Current perspectives on Chinese medicines and dietary supplements in China, Japan and the United States. Journal of Food and Drug Analysis 8: 219-228.
4. Luo GA, Liang QL, Zhang RL, Wang YM, Liu QF, et al. (2006) Study of chemieal matteromies and prescription of Traditional Chinese Medicine and an analysis of material foundation of compound prescription Qingkailing. Shi Jie Ke Xue Ji Shu - Zhong Yi Yao Xian Dai Hua 8: 6-15.
5. Zhang ZJ (2006) Research on pharmacodynamic characteristics analysis of genes'expression profile weighing the advantages and disadvantages of Chinese medicine prescription compatibility treating cerebral ischemia. Thesis, Beijing: Beijing University of Traditional Chinese Medicine 31-48.
6. Zhang ZJ, Wang Z, Li PT, Zhang WS, Li XY, et al. (2006) The pharmacodynamic evaluation of QKL combination herbs on focal cerebral ischemia-reperfusion injury. Zhong Guo Yao Li Xue Tong Bao 22: 964-967.
7. Ji C, Li Q, Aisa H, Yang N, Dong YL, et al. (2009) Gossypium herbaceam extracts attenuate ibotenic acid-induced excitotoxicity in rat hippocampus. J Alzheimer Dis 16: 331-339.
8. Zola SM, Squire LR, Teng E, Stefanacci L, Buffalo EA, et al. (2000) Impaired recognition memory in monkeys after damage limited to the hippocampal region. J Neurosci 20: 451-463.
9. Clark RE, Zola SM, Squire LR, (2000) Impaired recognition memory in rats after damage to the hippocampus. J Neurosci 20: 8853-8860.
10. Nordberg A, Jelic V, Arnáize E, Långström B, Almkvist O (2001) Brain functional imaging in early and preclinical Alzheimer's disease. In: Iqbal K, Sisodia SS, Winblad B, editors. Alzheimer's Disease: Advances in Etiology, Pathogenesis and Therapeutics. Chichester: John Wiley & Sons Ltd. 153-164.
11. Kovâcs T, Cairns NJ, Lantos PL, (2001) Olfactory centres in Alzheimer's disease: olfactory bulb is involved in early Braak's stages. NeuroReport 12: 285-288.
12. Reilly JF, Games D, Rydel RE, Freedman S, Schenk D, et al. (2003) Amyloid deposition in the hippocampus and entorhinal cortex: Quantitative analysis of a transgenic mouse model. Proc Natl Acad Sci USA 100: 4837-4842.
13. Matt N, Schmidt CK, Dupé V, Dennefeld C, Nau H, et al. (2005) Contribution of cellular retinol-binding protein type 1 to retinol metabolism during mouse development. Dev Dyn 233: 167-176.
14. Farias EF, Ong DE, Ghyselinck NB, Nakajo S, Kuppumbatti YS, et al. (2005) Cellular retinol-binding protein I, a regulator of breast epithelial retinoic acid receptor activity, cell differentiation, and tumorigenicity. J Natl Cancer Inst 97: 21-29.
15. Corcoran JPT, So PL, Maden M, (2004) Disruption of the retinoid signalling pathway causes a deposition of amyloid β in the adult rat brain. Eur J Neurosci 20: 896-902.
16. Etchamendy N, Enderlin V, Marighetto A, Vouimba RM, Pallet V, et al. (2001) Alleviation of a selective age-related relational memory deficit in mice by pharmacologically induced normalization of brain retinoid signaling. J Neurosci 21: 6423-6429.
17. Ding Y, Qiao A, Wang ZQ, Goodwin JS, Lee ES, et al. (2008) Retinoic acid attenuates β-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model. J Neurosci 28: 11622-11634.
18. Sarang SS, Yoshida T, Cadet R, Valeras AS, Jensen RV, et al. (2002) Discovery of molecular mechanisms of neuroprotection using cell-based bioassays and oligonucleotide arrays. Physiol Genomics 11: 45-52.
19. Ono K, Yoshiike Y, Takashima A, Hasegawa K, Naiki H, et al. (2004) Vitamin A exhibits potent antiamyloidogenic and fibril-destabilizing effects in vitro. Exp Neurol 189: 380-392.
20. Wang TW, Zhang H, Parent JM, (2005) Retinoic acid regulates postnatal neurogenesis in the murine subventricular zone-olfactory bulb pathway. Development 132: 2721-2732.
21. Cui J, Yag W, Wang J, Li K, Wang J, (2003) Influence of retinoic acid on proliferation and differentiation of neural stem cells from embryonic rat. Zhong Guo Zu Zhi Hua Xue Yu Xi Bao Hua Xue Za Zhi 12: 81-85.
22. Takahashi J, Palmer TD, Gage FH, (1999) Retinoic acid and neurotrophins collaborate to regulate neurogenesis in adult-derived neural stem cell cultures. J Neurobiol 38: 65-81.
23. Christie VB, Maltmana DJ, Hendersona AP, Whiting A, Marder TB, et al. (2010) Retinoid supplementation of differentiating human neural progenitors and embryonic stem cells leads to enhanced neurogenesis in vitro. J Neurosci Meth 193: 239-245.
24. Encinas M, Iglesias M, Liu Y, Wang HY, Muhaisen A, et al. (2000) Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J Neurochem 75: 991-1003.
25. Zhao BQ, Guo YR, Li XL, Zang T, Qu HY, et al. (2011) Amelioration of dementia induced by Aβ22-35 through rectal delivery of undecapeptide-hEGF to mouse brain. Int J Pharm 405: 1-8.
26. Chen-Plotkin AS, Hu WT, Siderowf A, Weintraub D, Gross RG, et al. (2011) Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease. Ann Neurol 69: 655-663.
27. Flore M, Triaca V, Amendola T, Tirassa P, Aloe L, (2002) Brain NGF and EGF administration improves passive avoidance response and stimulates brain precursor cells in aged male mice. Physiol Behav 77: 437-443.
28. Morrison RS, Keating RF, Moskal JR, (1988) Basic fibroblast growth factor and epidermal growth factor exert differential trophic effects on CNS neurons. J Neurosci Res 21: 71-79.
29. Abe K, Saito H, (1992) Protective effect of epidermal growth factor on glutamate neurotoxicity in cultured cerebellar neurons. Neurosci Res 14: 117-123.
30. Hicks D, Heidinger V, Mohand-Said S, Sahel J, Dreyfus H, (1998) Growth factors and gangliosides as neuroprotective agents in excitotoxicity and ischemia. Gen Pharmacol 30: 265-273.
31. Kuhn HG, Winkler J, Kempermann G, Thal LJ, Gage FH, (1997) Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J Neurosci 17: 5820-5829.
32. Benoit BO, Savarese T, Joly M, Engstrom CM, Pang LZ, et al. (2001) Quesenberry, Neurotrophin channeling of neural progenitor cell differentiation. J Neurobiol 46: 265-280.
33. Marchal-Victorion S, Deleyrolle L, de Weille J, Saunier M, Dromard C, et al. (2003) The human NTERA2 neural cell line generates neurons on growth under neural stem cell conditions and exhibits characteristics of radial glial cells. Mol Cell Neurosci 24: 198-213.
34. Yu J, Zeng J, Cheung RT, Xiong L, He MX, et al. (2009) Intracerebroventricular injection of epidermal growth factor reduces neurological deficit and infarct volume and enhances nestin expression following focal cerebral infarction in adult hypertensive rats. Clin Exp Pharmacol Physiol 36: 539-546.
35. Laskowski A, Schmidt W, Dinkel K, Martinez-Sanchez M, Reymann KG, (2005) bFGF and EGF modulate trauma-induced proliferation and neurogenesis in juvenile organotypic hippocampal slice cultures. Brain Res 1037: 78-89.
36. Calzà L, Giuliani A, Fernandez M, Pirondi S, D'Intino G, et al. (2003) Neural stem cells and cholinergic neurons: Regulation by immunolesion and treatment with mitogens, retinoic acid, and nerve growth factor. Proc Natl Acad Sci USA 100: 7325-7330.
37. Yamada M, Satoh T, Mori M, (2003) Mice lacking the thyrotropin-releasing hormone gene: what do they tell us? Thyroid 13: 1111-1121.
38. Mellow AM, Sunderland T, Cohen RM, Lawlor BA, Hill JL, et al. (1989) Acute effects of high-dose thyrotropin releasing hormone infusions in Alzheimer's disease. Psychopharmacology 98: 403-407.
39. Miyamoto M, Hirai K, Heya T, Nagaoka A, (1994) Effects of a sustained release formulation of thyrotropin-releasing hormone on behavioral abnormalities in senescence-accelerated mice. Eur J Pharmacol 271: 357-366.
40. Bennett GW, Ballard TM, Watson CD, Fone KC, (1997) Effect of neuropeptides on cognitive function. Exp Gerontol 32: 451-469.
41. Luo LG, Yano N, Mao QF, Jackson IMD, Stopa EG, (2002) Thyrotropin releasing hormone (TRH) in the hippocampus of Alzheimer patients. J Alzheimers Dis 4: 97-103.
42. Maser E, (2006) Neuroprotective role for carbonyl reductase? Biochem Biophy Res Co 340: 1019-1022.
43. Rashid MA, Lee S, Tak E, Lee J, Choi TG, et al. (2010) Carbonyl reductase 1 protects pancreatic β-cells against oxidative stress-induced apoptosis in glucotoxicity and glucolipotoxicity. Free Radical Bio Med 49: 1522-1533.
44. Tak E, Lee S, Lee J, Rashid MA, Kim YW, et al. (2011) Human carbonyl reductase 1 upregulated by hypoxia renders resistance to apoptosis in hepatocellular carcinoma cells. J Hepatol 54: 328-339.
45. Botella JA, Ulschmid JK, Gruenewald C, Moehle C, Kretzschmar D, et al. (2004) The Drosophila carbonyl reductase sniffer prevents oxidative stress-induced neurodegeneration. Curr Biol 14: 782-786.
46. Kehoe PG, Russ C, McIlory S, Williams H, Holmans P, et al. (1999) Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease. Nat Genet 21: 71-72.
47. Zou K, Yamaguchi H, Akatsu H, Sakamoto T, Ko M, et al. (2007) Angiotensin-converting enzyme converts amyloid β-protein 1-42 (Aβ1-42) to Aβ1-40, and its inhibition enhances brain Aβ deposition. J Neurosci 27: 8628-8635.
48. Hu J, Igarashi A, Kamata M, Nakagawa H, (2001) Angiotensin-converting enzyme degrades Alzheimer amyloid β-peptide (Aβ); retards Aβ aggregation, deposition, fibril formation; and inhibits cytotoxicity. J Biol Chem 276: 47863-47868.
49. Kim DH, Kim HK, Park S, Kim JY, Zou Y, et al. (2006) Short-term feeding of baicalin inhibits age-associated NF-kB activation. Mech Ageing Dev 127: 719-725.
50. Heo H, Shin Y, Cho W, Choi YS, Kim H, et al. (2009) Memory improvement in ibotenic acid induced model rats by extracts of Scutellaria baicalensis. J Eth Pharm 122: 20-27.
51. Li M, Tsang KS, Choi ST, Li K, Shaw PC, et al. (2011) Neuronal differentiation of C17.2 neural stem cells induced by a natural flavonoid, baicalin. Chembiochem 12: 449-456.
52. Tanaka M, Yamazaki M, Chiba K, (2009) Neuroprotective action of genipin on tunicamycin-induced cytotoxicity in neuro2a cells. Biol Pharm Bull 32: 1220-1223.
53. Yamazaki M, Chiba K, Yoshikawa C, (2009) Genipin suppresses A23187-induced cytotoxicity in neuro2a cells. Biol Pharm Bull 32: 1043-1046.
54. Koriyama Y, Chiba K, Yamazaki M, Suzuki H, Muramoto K, et al. (2010) Long-acting genipin derivative protects retinal ganglion cells from oxidative stress models in vitro and in vivo through the Nrf2/antioxidant response element signaling pathway. J Neurochem 115: 79-91.
55. Zhong XG, Li PT, Wang YY, (2004) Influence of the effective fractions of Qingkailing on the levels of neurotrophic factors in the brain of the rat with cerebral ischemia. Bei Jing Zhong Yi Yao Da Xue Xue Bao 27: 21-24.
56. Arai Y, Funatsu N, Numayama-Tsuruta K, Nomura T, Nakamura S, et al. (2005) Role of Fabp7, a downstream gene of Pax6, in the maintenance of neuroepithelial cells during early embryonic development of the rat cortex. The Journal of neuroscience 25: 9752-9761.
57. Boneva NB, Kaplamadzhiev DB, Sahara S, Kikuchi H, Pyko IV, et al. (2011) Expression of fatty acid-binding proteins in adult hippocampal neurogenic niche of postischemic monkeys. Hippocampus 21: 162-171.
58. Akama K, Horikoshi T, Nakayama T, Otsu M, Imaizumi N, et al. (2011) Proteomic identification of differentially expressed genes in neural stem cells and neurons differentiated from embryonic stem cells of cynomolgus monkey (Macaca fascicularis) in vitro. Biochimica et Biophysica Acta (BBA)-Proteins & Proteomics 1814: 265-276.
59. Beattie J, Allan GJ, Lochrie JD, Flint DJ, (2006) Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis. Biochemical Journal 395: 1.
60. Hauck SM, Gloeckner CJ, Harley ME, Schoeffmann S, Boldt K, et al. (2008) Identification of paracrine neuroprotective candidate proteins by a functional assay-driven proteomics approach. Molecular & Cellular Proteomics 7: 1349-1361.
61. Paspalas CD, Perley CC, Venkitaramani DV, Goebel-Goody SM, Zhang YF, et al. (2009) Major Vault Protein is Expressed along the Nucleus-Neurite Axis and Associates with mRNAs in Cortical Neurons. Cerebral Cortex 19: 1666-1677.
62. Salama RHM, Muramatsu H, Zou P, Okayama M, Muramatsu T, (2006) Midkine, a heparin-binding growth factor, produced by the host enhances metastasis of Lewis lung carcinoma cells. Cancer letters 233: 16-20.
63. Kim YB, Ryu JK, Lee HJ, Lim IJ, Park D, et al. (2010) Midkine, heparin-binding growth factor, blocks kainic acid-induced seizure and neuronal cell death in mouse hippocampus. BMC neuroscience 11: 42.
64. Ishikawa E, Ooboshi H, Kumai Y, Takada J, Nakamura K, et al. (2009) Midkine gene transfer protects against focal brain ischemia and augments neurogenesis. Journal of the neurological sciences 285: 78-84.
65. Pattnaik BR, Hughes BA, (2009) Regulation of Kir channels in bovine retinal pigment epithelial cells by phosphatidylinositol 4, 5-bisphosphate. American Journal of Physiology-Cell Physiology 297: C1001-C1011.
66. Bi W, Yan J, Shi X, Yuva-Paylor LA, Antalffy BA, et al. (2007) Rai1 deficiency in mice causes learning impairment and motor dysfunction, whereas Rai1 heterozygous mice display minimal behavioral phenotypes. Human molecular genetics 16: 1802-1813.
67. Hoffrogge R, Mikkat S, Scharf C, Beyer S, Christoph H, et al. (2006) 2-DE proteome analysis of a proliferating and differentiating human neuronal stem cell line (ReNcell VM). Proteomics 6: 1833-1847.
68. Xiao L, Ma Z, Li X, Lin Q, Que H, et al. (2005) cDNA microarray analysis of spinal cord injury and regeneration related genes in rat. ACTA PHYSIOLOGICA SINICA-CHINESE EDITION- 57: 705.
69. Cunha-Reis D, Ribeiro JA, Sebastião AM, (2006) VPAC2 receptor activation mediates VIP enhancement of population spikes in the CA1 area of the hippocampus. Annals of the New York Academy of Sciences 1070: 210-214.
70. Rangon CM, Goursaud S, Medja F, Lelièvre V, Mounien L, et al. (2005) VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice. Journal of Pharmacology and Experimental Therapeutics 314: 745-752.
71. Zaben M, John Sheward W, Shtaya A, Abbosh C, Harmar AJ, et al. (2009) The neurotransmitter VIP expands the pool of symmetrically dividing postnatal dentate gyrus precursors via VPAC2 receptors or directs them toward a neuronal fate via VPAC1 receptors. Stem Cells 27: 2539-2551.
72. Johansson K, Järvliden J, Gogvadze V, Morgenstern R, (2010) Multiple roles of microsomal glutathione transferase 1 in cellular protection: a mechanistic study. Free Radical Biology and Medicine 49: 1638-1645.
73. Bergink S, Severijnen LA, Wijgers N, Sugasawa K, Yousaf H, et al. (2006) The DNA repair-ubiquitin-associated HR23 proteins are constituents of neuronal inclusions in specific neurodegenerative disorders without hampering DNA repair. Neurobiology of disease 23: 708-716.
74. Fujita J, (1999) Cold shock response in mammalian cells. J Mol Microbiol Biotechnol 1: 243-255.
75. Wellmann S, Bührer C, Moderegger E, Zelmer A, Kirschner R, et al. (2004) Oxygen-regulated expression of the RNA-binding proteins RBM3 and CIRP by a HIF-1-independent mechanism. Journal of cell science 117: 1785-1794.
76. Sakurai T, Itoh K, Higashitsuji H, Nonoguchi K, Liu Y, et al. (2006) Cirp protects against tumor necrosis factor-α-induced apoptosis via activation of extracellular signal-regulated kinase. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1763: 290-295.
77. Zannis VI, Koukos G, Drosatos K, Vezeridis A, Zanni EE, et al. (2008) Discrete roles of apoA-I and apoE in the biogenesis of HDL species: lessons learned from gene transfer studies in different mouse models. Annals of medicine 40: 14-28.
78. Lee JW, Choi S, Lee S, Kwak TK, Kim HJ, et al. (2009) Cooperation between integrin alpha5 and tetraspan TM4SF5 regulates VEGF-mediated angiogenic activity.
79. Sultana R, Butterfield DA, (2007) Regional expression of key cell cycle proteins in brain from subjects with amnestic mild cognitive impairment. Neurochemical research 32: 655-662.